Treatments

Substances like D9-THC are now a promising allied treating Cancer Symptoms, and furthermore, destroying compromised cells

Cancer

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). (2019)

Abstract

A major strength of this study is that it will target symptom burden as a whole, rather than just individual symptoms, in an attempt to describe the general improvement in wellbeing previously reported by some patients in open label, non controlled trials of medicinal cannabis[…]

Author Information

Good P, Haywood A, Gogna G, Martin J, Yates P, Greer R, Hardy J.

Mater Health Services, Mater Research Institute-University of Queensland, St Vincent’s Private Hospital Brisbane, Brisbane, Qld, Australia. Phillip.Good@mater.org.au. School of Pharmacy and Pharmacology, Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia. Mater Research Institute – The University of Queensland, Brisbane, Australia. Greenslopes Private Hospital, Gold Coast Health Service, Greenslopes, Australia. The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, Australia. Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Callaghan, Australia. School of Nursing, Queensland University of Technology, Victoria Park Rd, Kelvin Grove, QLD, 4059, Australia. Centre for Palliative Care Research and Education, Queensland Health, Brisbane, Australia.
Torus Research, Mater Research Institute-University of Queensland, QLD, St Lucia, Australia. Mater Health Services, Mater Research Institute-University of Queensland, Brisbane, Queensland, Australia.

Cannabis for the Management of Cancer Symptoms: THC Version 2.0? (2018)

Abstract

This study provides a precious piece of information on the use of medical cannabis for the management of cancer symptoms. The sample population was large, and a prospective follow-up with rather high adherence and response rates was achieved[…]

Author Information

Manuel Guzmán

Department of Biochemistry and Molecular Biology, CIBERNED, IUIN and IRYCIS, Complutense University, Madrid, Spain.

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. (2018)

Abstract

Breast cancer is the second leading cause of death among women. Although early diagnosis and development of new treatments have improved their prognosis, many patients present innate or acquired resistance to current therapies[…]

Author Information

Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, García-Taboada E, Wade J, Smith S, Guzmán M, Pérez-Gómez E, Gordon M, Sánchez C.

Complutense University, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. Aunt Zelda’s, CA, United States. Complutense University, Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, CIBERNED and IUIN, Madrid, Spain.

Use of medical cannabis: perceptions of Israeli oncologists. (2019)

Abstract

The use of the cannabis plant (Cannabis sativa) for the treatment of various cancer-related symptoms, including pain, cachexia, anxiety, and chemotherapy-induced nausea and vomiting, is constantly increasing worldwide. The plant contains hundreds of active compounds[…]

Author Information

Mirelman D, Waissengrin B, Goldway N, Sharon H, Brill S, Wolf I.

Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Institute of Pain Medicine, Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Institute of Pain Medicine, Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: idow@tlvmc.gov.il.

Cannabinoids: a new hope for breast cancer therapy? (2012)

Abstract

Breast cancer is a very common disease that affects approximately 1 in 10 women at some point in their lives. Importantly, breast cancer cannot be considered a single disease as it is characterized by distinct pathological and molecular subtypes that are treated with different therapies[…]

Author Information

Caffarel MM1, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C.

Dept. Biochemistry and Molecular Biology I, School of Biology, Complutense University-CIBERNED-IRYCIS, Madrid, Spain.

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. (2011)

Abstract

Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. When these tumors are in advanced stages, few therapeutic options are available. Therefore, it is essential to search for new treatments to fight this disease. In this study, we investigated the effects of cannabinoids–a novel family of potential anticancer agents–on the growth of HCC[…]

Author Information

Vara D, Salazar M, Olea-Herrero N, Guzmán M, Velasco G, Díaz-Laviada I.

Department of Biochemistry and Molecular Biology, School of Medicine, Alcalá University, Madrid, Spain.

Cannabinoids and gliomas. (2007)

Abstract

Cannabinoids, the active components of Cannabis sativa L., act in the body by mimicking endogenous substances–the endocannabinoids–that activate specific cell surface receptors. Cannabinoids exert various palliative effects in cancer patients. In addition, cannabinoids inhibit the growth of different types of tumor cells[…]

Author Information

Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M.

Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, 28040 Madrid, Spain.

Treatments
_